1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	kappa	kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	subunit	subunit	_	_	_	_	_	_	_
8	p65	p65	_	_	_	_	_	_	_
9	mRNA	mrna	_	_	_	_	_	_	_
10	accumulation	accumulation	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	lipopolysaccharide-stimulated	lipopolysaccharide-stimulated	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	monocytic	monocytic	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	treated	treat	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	sodium	sodium	_	_	_	_	_	_	_
19	salicylate	salicylate	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Lipopolysaccharide	Lipopolysaccharide	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	one	one	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	most	most	_	_	_	_	_	_	_
7	potent	potent	_	_	_	_	_	_	_
8	trigger	trigger	_	_	_	_	_	_	_
9	substances	substance	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	monocytes	monocyte	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	macrophages	macrophage	_	_	_	_	_	_	_
14	causing	cause	_	_	_	_	_	_	_
15	secretion	secretion	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	inflammatory	inflammatory	_	_	_	_	_	_	_
18	mediators	mediator	_	_	_	_	_	_	_
19	such	such	_	_	_	_	_	_	_
20	as	as	_	_	_	_	_	_	_
21	tumor	tumor	_	_	_	_	_	_	_
22	necrosis	necrosis	_	_	_	_	_	_	_
23	factor	factor	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	interleukin-1	interleukin-1	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	nature	nature	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	nuclear	nuclear	_	_	_	_	_	_	_
6	factors	factor	_	_	_	_	_	_	_
7	involved	involve	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	regulation	regulation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	these	these	_	_	_	_	_	_	_
12	cytokine	cytokine	_	_	_	_	_	_	_
13	genes	gene	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	still	still	_	_	_	_	_	_	_
16	unknown	unknown	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	kappa	kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	;	;	_	_	_	_	_	_	_
9	heterodimer	heterodimer	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	p50	p50	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	p65	p65	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	proteins	protein	_	_	_	_	_	_	_
16	have	have	_	_	_	_	_	_	_
17	been	be	_	_	_	_	_	_	_
18	suggested	suggest	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	play	play	_	_	_	_	_	_	_
21	an	an	_	_	_	_	_	_	_
22	important	important	_	_	_	_	_	_	_
23	role	role	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	gene	gene	_	_	_	_	_	_	_
26	transcription	transcription	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	inflammatory	inflammatory	_	_	_	_	_	_	_
29	mediators	mediator	_	_	_	_	_	_	_
30	when	when	_	_	_	_	_	_	_
31	monocytes	monocyte	_	_	_	_	_	_	_
32	are	be	_	_	_	_	_	_	_
33	stimulated	stimulate	_	_	_	_	_	_	_
34	with	with	_	_	_	_	_	_	_
35	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Nonsteroidal	nonsteroidal	_	_	_	_	_	_	_
2	anti-inflammatory	anti-inflammatory	_	_	_	_	_	_	_
3	drugs	drug	_	_	_	_	_	_	_
4	such	such	_	_	_	_	_	_	_
5	as	as	_	_	_	_	_	_	_
6	salicylates	salicylate	_	_	_	_	_	_	_
7	have	have	_	_	_	_	_	_	_
8	been	be	_	_	_	_	_	_	_
9	used	use	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	treat	treat	_	_	_	_	_	_	_
12	symptoms	symptom	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	inflammation	inflammation	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	new	new	_	_	_	_	_	_	_
19	mechanism	mechanism	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	drug	drug	_	_	_	_	_	_	_
22	action	action	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	suggested	suggest	_	_	_	_	_	_	_
25	recently	recently	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Salicylates	salicylate	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	lipopolysaccharide-induced	lipopolysaccharide-induced	_	_	_	_	_	_	_
8	gene	gene	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	via	via	_	_	_	_	_	_	_
11	inhibition	inhibition	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	preventing	prevent	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	degradation	degradation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	NF-kappa	NF-kappa	_	_	_	_	_	_	_
22	B	B	_	_	_	_	_	_	_
23	inhibitor	inhibitor	_	_	_	_	_	_	_
24	“	``	_	_	_	_	_	_	_
25	I	i	_	_	_	_	_	_	_
26	kappa	kappa	_	_	_	_	_	_	_
27	B	B	_	_	_	_	_	_	_
28	”	''	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	blocking	block	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	translocation	translocation	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	NF-kappa	NF-kappa	_	_	_	_	_	_	_
35	B	B	_	_	_	_	_	_	_
36	into	into	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	nuclear	nuclear	_	_	_	_	_	_	_
39	compartment	compartment	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	nature	nature	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	subunit	subunit	_	_	_	_	_	_	_
8	involved	involve	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	this	this	_	_	_	_	_	_	_
11	mechanism	mechanism	_	_	_	_	_	_	_
12	has	have	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	been	be	_	_	_	_	_	_	_
15	defined	define	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	examine	examine	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	mechanisms	mechanism	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	which	which	_	_	_	_	_	_	_
7	salicylates	salicylate	_	_	_	_	_	_	_
8	affect	affect	_	_	_	_	_	_	_
9	cytokine	cytokine	_	_	_	_	_	_	_
10	gene	gene	_	_	_	_	_	_	_
11	transcription	transcription	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	amount	amount	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	active	active	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	inactive	inactive	_	_	_	_	_	_	_
19	NF-kappa	NF-kappa	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	NF-kappa	NF-kappa	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	mRNA	mRNA	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	Porphyromonas	Porphyromonas	_	_	_	_	_	_	_
28	gingivalis	gingivalis	_	_	_	_	_	_	_
29	lipopolysaccharide-stimulated	lipopolysaccharide-stimulated	_	_	_	_	_	_	_
30	human	human	_	_	_	_	_	_	_
31	monocytic	monocytic	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	was	be	_	_	_	_	_	_	_
34	assessed	assess	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	High	high	_	_	_	_	_	_	_
2	doses	dose	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	sodium	sodium	_	_	_	_	_	_	_
5	salicylate	salicylate	_	_	_	_	_	_	_
6	suppressed	suppress	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	p65	p65	_	_	_	_	_	_	_
10	mRNA	mrna	_	_	_	_	_	_	_
11	accumulation	accumulation	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	resulting	result	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	suppression	suppression	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	total	total	_	_	_	_	_	_	_
18	NF-kappa	NF-kappa	_	_	_	_	_	_	_
19	B	B	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	p50	p50	_	_	_	_	_	_	_
22	on	on	_	_	_	_	_	_	_
23	tissue	tissue	_	_	_	_	_	_	_
24	oligonucleotide	oligonucleotide	_	_	_	_	_	_	_
25	had	have	_	_	_	_	_	_	_
26	no	no	_	_	_	_	_	_	_
27	effects	effect	_	_	_	_	_	_	_
28	on	on	_	_	_	_	_	_	_
29	lipopolysaccharide-induced	lipopolysaccharide-induced	_	_	_	_	_	_	_
30	NF-kappa	NF-kappa	_	_	_	_	_	_	_
31	B	B	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	p65	p65	_	_	_	_	_	_	_
7	subunit	subunit	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	inhibited	inhibit	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	salicylate	salicylate	_	_	_	_	_	_	_
15	treatment	treatment	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	highlight	highlight	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	role	role	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	salicylate	salicylate	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	control	control	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	gene	gene	_	_	_	_	_	_	_
27	expression	expression	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	inflammatory	inflammatory	_	_	_	_	_	_	_
30	mediators	mediator	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

